China Shineway Pharmaceutical Group Limited Financial Flexibility Index
China Shineway Pharmaceutical Group Limited financial flexibility index. China Shineway Pharmaceutical Group Limited (C1S) has a Financial Flexibility Index of 0.08x as of June 2023. Free cash flow of €185.26 Million (operating CF €160.69 Million minus capex €24.57 Million) represents 0% of total liabilities (€2.26 Billion). See C1S cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of China Shineway Pharmaceutical Group Limited (2013–2025)
Financial flexibility index of China Shineway Pharmaceutical Group Limited from 2013 to 2025. Historical Financial Flexibility Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. Check China Shineway Pharmaceutical Group Limi (C1S) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
China Shineway Pharmaceutical Group Limited Financial Flexibility Index by Year (2013–2025)
China Shineway Pharmaceutical Group Limited financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for China Shineway Pharmaceutical Group Limited. For the full cash flow conversion analysis, see China Shineway Pharmaceutical Group Limi cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | €1.37 Billion | €1.17 Billion | €2.72 Billion | ▲ +17.7% |
| 2024 | 0.43x | €1.10 Billion | €963.13 Million | €2.57 Billion | ▲ +1.0% |
| 2023 | 0.42x | €1.08 Billion | €932.63 Million | €2.54 Billion | ▼ -36.7% |
| 2022 | 0.67x | €1.24 Billion | €1.11 Billion | €1.85 Billion | ▲ +9.5% |
| 2021 | 0.61x | €796.78 Million | €703.15 Million | €1.30 Billion | ▲ +23.2% |
| 2020 | 0.50x | €704.59 Million | €638.57 Million | €1.42 Billion | ▲ +47.3% |
| 2019 | 0.34x | €456.40 Million | €368.00 Million | €1.35 Billion | ▼ -50.7% |
| 2018 | 0.68x | €659.92 Million | €532.59 Million | €966.01 Million | ▼ -1.0% |
| 2017 | 0.69x | €582.47 Million | €490.65 Million | €844.16 Million | ▼ -31.1% |
| 2016 | 1.00x | €840.32 Million | €733.53 Million | €838.59 Million | ▲ +0.9% |
| 2015 | 0.99x | €851.26 Million | €744.71 Million | €857.13 Million | ▲ +14.8% |
| 2014 | 0.86x | €877.34 Million | €773.16 Million | €1.01 Billion | ▲ +44.8% |
| 2013 | 0.60x | €781.77 Million | €519.89 Million | €1.31 Billion | — |